Institute of Oncology Ljubljana, Department of Experimental Oncology, Ljubljana, Slovenia.
Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia.
Radiol Oncol. 2021 Nov 19;55(4):379-392. doi: 10.2478/raon-2021-0042.
MicroRNAs (miRNAs) are short non-coding RNAs that play important roles in almost all biological pathways. They regulate post-transcriptional gene expression by binding to the 3'untranslated region (3'UTR) of messenger RNAs (mRNAs). MitomiRs are miRNAs of nuclear or mitochondrial origin that are localized in mitochondria and have a crucial role in regulation of mitochondrial function and metabolism. In eukaryotes, mitochondria are the major sites of oxidative metabolism of sugars, lipids, amino acids, and other bio-macromolecules. They are also the main sites of adenosine triphosphate (ATP) production.
In the review, we discuss the role of mitomiRs in mitochondria and introduce currently well studied mitomiRs, their target genes and functions. We also discuss their role in cancer initiation and progression through the regulation of mRNA expression in mitochondria. MitomiRs directly target key molecules such as transporters or enzymes in cell metabolism and regulate several oncogenic signaling pathways. They also play an important role in the Warburg effect, which is vital for cancer cells to maintain their proliferative potential. In addition, we discuss how they indirectly upregulate hexokinase 2 (HK2), an enzyme involved in glucose phosphorylation, and thus may affect energy metabolism in breast cancer cells. In tumor tissues such as breast cancer and head and neck tumors, the expression of one of the mitomiRs (miR-210) correlates with hypoxia gene signatures, suggesting a direct link between mitomiR expression and hypoxia in cancer. The miR-17/92 cluster has been shown to act as a key factor in metabolic reprogramming of tumors by regulating glycolytic and mitochondrial metabolism. This cluster is deregulated in B-cell lymphomas, B-cell chronic lymphocytic leukemia, acute myeloid leukemia, and T-cell lymphomas, and is particularly overexpressed in several other cancers. Based on the current knowledge, we can conclude that there is a large number of miRNAs present in mitochondria, termed mitomiR, and that they are important regulators of mitochondrial function. Therefore, mitomiRs are important players in the metabolism of cancer cells, which need to be further investigated in order to develop a potential new therapies for cancer.
微小 RNA(miRNAs)是短的非编码 RNA,在几乎所有的生物途径中都发挥着重要作用。它们通过与信使 RNA(mRNA)的 3'非翻译区(3'UTR)结合来调节转录后基因表达。MitomiRs 是源自核或线粒体的 miRNA,定位于线粒体,在调节线粒体功能和代谢方面发挥着关键作用。在真核生物中,线粒体是糖、脂类、氨基酸和其他生物大分子的主要氧化代谢部位。它们也是三磷酸腺苷(ATP)产生的主要部位。
在综述中,我们讨论了 mitomiRs 在线粒体中的作用,并介绍了目前研究较多的 mitomiRs、它们的靶基因和功能。我们还讨论了它们通过调节线粒体中 mRNA 的表达在癌症的发生和发展中的作用。MitomiRs 直接靶向细胞代谢中的关键分子,如转运蛋白或酶,调节几种致癌信号通路。它们在对癌细胞维持其增殖潜能至关重要的沃伯格效应中也发挥着重要作用。此外,我们还讨论了它们如何间接上调参与葡萄糖磷酸化的酶-己糖激酶 2(HK2),从而可能影响乳腺癌细胞的能量代谢。在乳腺癌和头颈部肿瘤等肿瘤组织中,一种 mitomiR(miR-210)的表达与缺氧基因特征相关,这表明 mitomiR 表达与癌症中的缺氧之间存在直接联系。miR-17/92 簇已被证明通过调节糖酵解和线粒体代谢,是肿瘤代谢重编程的关键因素。该簇在 B 细胞淋巴瘤、B 细胞慢性淋巴细胞白血病、急性髓细胞白血病和 T 细胞淋巴瘤中失调,在其他几种癌症中尤其过表达。基于目前的知识,我们可以得出结论,线粒体中有大量的 miRNA,称为 mitomiR,它们是线粒体功能的重要调节因子。因此,mitomiRs 是癌细胞代谢的重要参与者,需要进一步研究,以便为癌症开发潜在的新疗法。